BioLab Holdings Invests in AI Diagnostic Tech with cureVision

September 04, 2025
BioLab Holdings, Inc. has announced a strategic investment in cureVision, a German health tech startup specializing in AI-driven wound care diagnostics.

BioLab Holdings, Inc. has announced a strategic investment and commercialization partnership with cureVision, a German health tech startup. Announced in a press release, this collaboration aims to introduce cureVision's AI-driven wound care technology to the U.S. market.

cureVision's technology utilizes optical sensors, 3D imaging, and artificial intelligence to provide fast, contact-free wound assessments. The system is certified under the European Medical Device Regulation (MDR) and offers comprehensive insights in under two minutes, streamlining the measurement, analysis, and documentation processes for healthcare professionals.

BioLab's investment will support cureVision's regulatory and reimbursement strategies in the U.S., leveraging BioLab's national distribution network. This partnership is expected to enhance wound care workflows by combining cureVision's advanced imaging capabilities with BioLab's clinical expertise.

The collaboration will also provide cureVision with access to U.S. market insights and guidance from BioLab's medical advisory group, aiming to improve patient outcomes and streamline wound care processes across healthcare settings.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/04
Hoth Therapeutics Adopts Lantern Pharma's AI Platform for Drug Development
09/04
Ketryx Secures $39M Series B to Enhance AI Compliance in Life Sciences
09/04
Proprio Adds Rocket Lab CFO Adam Spice to Board
09/04
Reveal HealthTech Secures $7.2M Series A for AI Healthcare Solutions
09/04
Laza Medical's AI Heart Model Achieves First Human Use

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like